Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

oxaliplatin

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

DNA synthesis inhibitor, DNA cross linking agent

Related drugs:

‹

cisplatin (330)

gemcitabine (181)

temozolomide (114)

cytarabine (99)

dacarbazine (22)

cytarabine/daunorubicin liposomal formulation (19)

clofarabine (16)

carmustine (14)

temozolomide gel (7)

fludarabine IV (6)

hydroxyurea (3)

mercaptopurine (3)

fotemustine (2)

streptozocin (2)

fludarabine oral (2)

thioguanine (2)

fosgemcitabine palabenamide (1)

asparagine cytarabine conjugate (1)

gemcitabine intravesical system (1)

mitomycin urothelial gel (1)

melphalan hepatic delivery system (1)

liposomal cisplatin (0)

pegylated liposomal mitomycin-c prodrug (0)

mercaptopurine oral suspension (0)

gemcitabine with RenovoCath (0)

cytarabine ocfosfate (0)

mitomycin intravesicular (0)

captisol-enabled melphalan (0)

idarubicin hydrochloride (16)

cisplatin liposomal (0)

demplatin pegraglumer (0)

›

No biomarker	Colon Cancer	No biomarker	Colon Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Pancreatic Cancer	No biomarker	Pancreatic Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
HER-2 negative	Gastroesophageal Junction Adenocarcinoma	HER-2 negative	Gastroesophageal Junction Adenocarcinoma	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
HER-2 negative	Gastric Cancer	HER-2 negative	Gastric Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	gemcitabine + paclitaxel + oxaliplatin Sensitive: A2 - Guideline gemcitabine + paclitaxel + oxaliplatin Sensitive : A2	gemcitabine + paclitaxel + oxaliplatin Sensitive: A2 - Guideline gemcitabine + paclitaxel + oxaliplatin Sensitive : A2
No biomarker	Gallbladder Cancer	No biomarker	Gallbladder Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Gastric Cancer	No biomarker	Gastric Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2